Conversion of Host Cell Receptor into Virus Destructor by Immunodisc to Neutralize Diverse SARS‐CoV‐2 Variants
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202302803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Jaehyeon Hwang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea. Hauptthemen laut MEDLINE: SARS-CoV-2, Angiotensin-Converting Enzyme 2, COVID-19, Antibodies, Neutralizing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Research Foundation of Korea, Basic Science Research Program, Ministry of Education.
Abstract (Originalsprache)
The decreasing efficacy of antiviral drugs due to viral mutations highlights the challenge of developing a single agent targeting multiple strains. Using host cell viral receptors as competitive inhibitors is promising, but their low potency and membrane‐bound nature have limited this strategy. In this study, the authors show that angiotensin‐converting enzyme 2 (ACE2) in a planar membrane patch can effectively neutralize all tested severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants that emerged during the COVID‐19 pandemic. The ACE2‐incorporated membrane patch implemented using nanodiscs replicated the spike‐mediated membrane fusion process outside the host cell, resulting in virus lysis, extracellular RNA release, and potent antiviral activity. While neutralizing antibodies became ineffective as the SARS‐CoV‐2 evolved to better penetrate host cells the ACE2‐incorporated nanodiscs became more potent, highlighting the advantages of using receptor‐incorporated nanodiscs for antiviral purposes. ACE2‐incorporated immunodisc, an Fc fusion nanodisc developed in this study, completely protected humanized mice infected with SARS‐CoV‐2 after prolonged retention in the airways. This study demonstrates that the incorporation of viral receptors into immunodisc transforms the entry gate into a potent virucide for all current and future variants, a concept that can be extended to different viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
- College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, 28644, Republic of Korea.
- Research Center, Mvrix Inc., Anyang, 14058, Republic of Korea.
- Department of Molecular Science and Technology, Ajou University, Suwon, 16499, Republic of Korea.
- Department of Biomedical Sciences, Graduate School, Korea University, Seoul, 02841, Republic of Korea.
- Synthetic Biology and Bioengineering Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
ORCID-Profile: Dae-Hyuk Kweon
Förderung
- National Research Foundation of Korea
- Basic Science Research Program
- Ministry of Education
- Korea Health Technology R&D
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
- Ministry of Science and ICT, South Korea
- Samsung Science and Technology Foundation
Zitieren
APA
Hwang, J., Kim, B. K., Moon, S., Park, W., Kim, K. W., Yoon, J. H., Oh, H., Jung, S., Park, Y., Kim, S., Kim, M., Kim, S., Jung, Y., Park, M., Kim, J. H., Jung, S. T., Kim, S. J., Kim, Y. S., Chung, W. J., …, & Kweon, D. H. (2024). Conversion of Host Cell Receptor into Virus Destructor by Immunodisc to Neutralize Diverse SARS‐CoV‐2 Variants. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202302803
Vancouver
Hwang J, Kim BK, Moon S, Park W, Kim KW, Yoon JH, et al. Conversion of Host Cell Receptor into Virus Destructor by Immunodisc to Neutralize Diverse SARS‐CoV‐2 Variants. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202302803
BibTeX
@article{Hwang2024,
author = {Hwang, Jaehyeon and Kim, Beom Kyu and Moon, Seokoh and Park, Wonbeom and Kim, Kyeong Won and Yoon, Jeong Hyeon and Oh, Hyunseok and Jung, Sangwon and Park, Youngseo and Kim, Suhyun and Kim, Misoo and Kim, Soomin and Jung, Younghun and Park, Myungseo and Kim, Jun-Ho and Jung, Sang Taek and Kim, Sang Jick and Kim, Yong-Sung and Chung, Woo-Jae and Song, Min-Suk and Kweon, Dae-Hyuk},
title = {Conversion of Host Cell Receptor into Virus Destructor by Immunodisc to Neutralize Diverse SARS‐CoV‐2 Variants},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202302803}
}
EUVIMED